BNTX · BioNTech SE · Share Buybacks
$86.00
+0.40 (+0.47%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$21.22B
Shares
247.93M
Volume · Nov 16
510.65K
Avg daily vol (3M)
1.23M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$1,000,000,000
as of 2026-09-30
· from Press release (reviewed)· through 2027-05-06
Program Utilization
46.3%
$463,300,000 used of $1,000,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| — | $1,000,000,000 | $536,700,000 | 2026-09-30 | 2027-05-06 | Press release , published 2026-11-03 |
Key facts
CIK
1776985
CUSIP
09075V102
13F (30d)
239 filings
212 filers
Visit website
Investor relations